TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012
TCL Archive Conversation with The Cancer Letter: Daniel Hayes Leads Tour of Caris Website August 8, 2014
TCL Archive Advisors Approve $50 Million NCI Effort To Attack Cancer On a Molecular Level July 2, 1999
TCL Archive PRI Purchased By DynCorp; NCI Is Assured No Changes Will Be Made At Frederick April 13, 1990
